ADHD

From the effects of caffeine on smokers with schizophrenia and bipolar disorder to the initiation of a trial for a new ADHD medication, here are highlights from the week in Psychiatric Times.

The first phase 3 clinical trial of CTx-1301 for the treatment of ADHD has begun.

From new advances in the treatment of postpartum depression to digital therapeutics for the treatment of ADHD in children, here are highlights from the week in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the December 2022 issue of Psychiatric Times.

From an in-depth analysis of ADHD in clinical practice to differences in effectiveness between intravenous and intranasal ketamine, here are highlights from the week in Psychiatric Times.

The investigators suggested that future research explore the connection between ADHD risk in children and depression in pregnant parents.

Take a look at this bread-and-butter case of ADHD from a child psychiatry clinic.

Screening for the symptom of worthlessness could save your adolescent patient’s life…

The experts weighed in on a wide variety of psychiatric issues for the November 2022 issue of Psychiatric Times.

What are the advances in adult ADHD?

ADHD is an all-day affair, and treating it in an adult population can be difficult.

From complementary and alternative approaches in the COVID-19 era to mental health’s most toxic myth, here are highlights from the week in Psychiatric Times.

There are no treatment guidelines for ADHD in adults in the United States, but you can still tackle this challenging diagnosis.

Why are more and more adult women being diagnosed with ADHD? A presentation at the APNA Annual Conference shed light on the issue.

Anthony Rostain, MD, MA, describes some of the signs and symptoms of adult attention-deficit/hyperactivity disorder (ADHD), as well as the impact on psychosocial skills.

Theresa Cerulli, MD, and Anthony Rostain, MD, MA, discuss the recent spike of adult attention-deficit/hyperactivity disorder (ADHD) diagnoses and how this has been impacted by COVID-19 and telehealth.

ADHD experts discuss factors that drive treatment selection when selecting therapy for an adult with ADHD.

Theresa Cerulli, MD, and Andrew J. Cutler, MD, provide insight on goals of therapy for patients with ADHD.

Stephen Faraone, PhD, presents the case of a 24-year-old patient with ADHD.

From traumatic brain injury to the dangers of excessive social media usage, here are highlights from the week in Psychiatric Times.

ADHD experts discuss the importance of an integrative approach in the treatment of adults with ADHD.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss addressing non-adherence and the stigma of ADHD.

Recent research determined the medications modafinil, atomoxetine, and guanfacine negatively impact bones.

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to deal with other comorbidities when treating an adult with ADHD.

Experts in psychiatry provide insight on a patient case as well as discuss challenges with ADHD.

Stephen Faraone, PhD, presents the case of a 23-year-old patient with ADHD.

A panel of ADHD specialists discuss the impact of treatment delay when dealing with an adult patient.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to co-manage a patient with ADHD with other specialties.

Experts in psychiatry discuss tips to differentiate between ADHD and other co-morbid psychiatric disorders.